Faron Pharmaceuticals Announces Board Changes

TURKU, Finland and BOSTON, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage bioph...

Related Keywords

Uppsala ,Uppsala Lan ,Sweden ,Norway ,Boston ,Massachusetts ,United States ,Jukka ,Lapland ,Finland ,North Market ,American ,Norwegian ,Bristol Myers Squibb ,Lytix Biopharma ,Christine Ann Roth ,Jo Turner ,Sensei Biotherapeutics ,Christopher Golden ,Juha Karttunen ,Christine Roth ,Frank Armstrong ,Jenniferc Smith Parker ,Sandy Jamieson ,Faron Pharmaceuticals Ltd ,Infinity Pharmaceuticals ,American Society Of Clinical Oncology ,Biovica Inc ,Vividion Therapeutics Inc ,Head Of Communications ,Cairn Financial Advisers ,American Society Of Hematology ,Directors Of The Company ,Peel Hunt ,Board Of Faron Pharmaceuticals ,Faron Pharmaceuticals ,Uppsala University ,Bayer Ag ,Biovica International ,Novartis ,University Of North Carolina At Chapel Hill ,First North ,Non Executive Directors ,Extraordinary General Meeting ,Ann Roth ,Executive Vice President ,Oncology Strategic Business Unit ,American Society ,Clinical Oncology ,North Carolina ,Nasdaq First North Growth Market ,Associate Professor ,Chief Medical Officer ,Faron Board ,Certified Adviser ,Nasdaq First ,